 | • レポートコード：MRC23Q36426 • 出版社/出版日：QYResearch / 2023年3月 • レポート形態：英文、PDF、81ページ • 納品方法：Eメール（2-3日） • 産業分類：医療機器 |
| Single User | ￥435,000 (USD2,900) | ▷ お問い合わせ |
| Enterprise License | ￥870,000 (USD5,800) | ▷ お問い合わせ |
• お支払方法：銀行振込（納品後、ご請求書送付）
レポート概要
| 本調査レポートは世界の腫瘍細胞分離キット市場について調査・分析し、世界の腫瘍細胞分離キット市場概要、市場トレンド、主要企業別競争状況、タイプ別セグメント分析（乳癌腫瘍細胞分離、黒色腫腫瘍細胞分離、卵巣癌腫瘍細胞分離、その他）、用途別セグメント分析（診断検査室、病院、専門クリニック、研究所、その他）、地域別市場規模、主要企業のプロファイルなどに関する情報を掲載しています。主要企業としては、Thermo Fisher Scientific、Miltenyi Biotec、Cell Biolabs, Inc.、STEMCELL Technologies Inc.、QIAGEN、Genekam、Menarini Silicon Biosystems, Inc.などが含まれています。 世界の腫瘍細胞分離キット市場は、2022年にXXX米ドル、2029年にはXXX米ドルに達すると予測され、予測期間の年平均成長率はXXX％です。COVID-19とロシア・ウクライナ戦争の影響は、腫瘍細胞分離キット市場規模を推定する際に考慮しました。本レポートは、腫瘍細胞分離キットの世界市場を定量的・定性的な分析により包括的に提示し、読者がビジネス/成長戦略を策定し、市場競争状況を把握し、現在の市場における自社のポジションを分析し、腫瘍細胞分離キットに関するビジネス上の意思決定に役立てることを目的としています。 ・腫瘍細胞分離キット市場の概要 - 腫瘍細胞分離キットのタイプ別セグメント - 世界の腫瘍細胞分離キット市場規模：タイプ別分析（乳癌腫瘍細胞分離、黒色腫腫瘍細胞分離、卵巣癌腫瘍細胞分離、その他） - 腫瘍細胞分離キットの用途別セグメント - 世界の腫瘍細胞分離キット市場規模：用途別分析（診断検査室、病院、専門クリニック、研究所、その他） - 世界の腫瘍細胞分離キット市場規模予測（2018年-2029年） ・腫瘍細胞分離キット市場の成長トレンド - 腫瘍細胞分離キットの地域別市場規模（2018年-2029年） - 腫瘍細胞分離キット市場ダイナミクス - 腫瘍細胞分離キットの業界動向 - 腫瘍細胞分離キット市場の成長ドライバ、課題、阻害要因 ・主要企業別競争状況 - 企業別市場シェア - 世界の主要企業、業界ランキング分析 - 市場への参入、M＆A動向 ・タイプ別セグメント：乳癌腫瘍細胞分離、黒色腫腫瘍細胞分離、卵巣癌腫瘍細胞分離、その他 - 世界の腫瘍細胞分離キットのタイプ別市場規模（2018年-2023年） - 世界の腫瘍細胞分離キットのタイプ別市場規模（2024年-2029年） ・用途別セグメント：診断検査室、病院、専門クリニック、研究所、その他 - 世界の腫瘍細胞分離キットの用途別市場規模（2018年-2023年） - 世界の腫瘍細胞分離キットの用途別市場規模（2024年-2029年） ・腫瘍細胞分離キットの地域別市場規模 - 北米の腫瘍細胞分離キット市場規模（2018年-2029年） - アメリカの腫瘍細胞分離キット市場規模（2018年-2029年） - ヨーロッパの腫瘍細胞分離キット市場規模（2018年-2029年） - アジア太平洋の腫瘍細胞分離キット市場規模（2018年-2029年） - 中国の腫瘍細胞分離キット市場規模（2018年-2029年） - 日本の腫瘍細胞分離キット市場規模（2018年-2029年） - 韓国の腫瘍細胞分離キット市場規模（2018年-2029年） - インドの腫瘍細胞分離キット市場規模（2018年-2029年） - オーストラリアの腫瘍細胞分離キット市場規模（2018年-2029年） - 中南米の腫瘍細胞分離キット市場規模（2018年-2029年） - 中東・アフリカの腫瘍細胞分離キット市場規模（2018年-2029年） ・主要企業のプロファイル：企業情報、事業概要、売上、動向 Thermo Fisher Scientific、Miltenyi Biotec、Cell Biolabs, Inc.、STEMCELL Technologies Inc.、QIAGEN、Genekam、Menarini Silicon Biosystems, Inc. ・アナリストの観点/結論 ・調査方法とデータソース |
Highlights
The global Tumor Cell Isolation Kits market was valued at US$ million in 2022 and is anticipated to reach US$ million by 2029, witnessing a CAGR of % during the forecast period 2023-2029. The influence of COVID-19 and the Russia-Ukraine War were considered while estimating market sizes.
North American market for Tumor Cell Isolation Kits is estimated to increase from $ million in 2023 to reach $ million by 2029, at a CAGR of % during the forecast period of 2023 through 2029.
Asia-Pacific market for Tumor Cell Isolation Kits is estimated to increase from $ million in 2023 to reach $ million by 2029, at a CAGR of % during the forecast period of 2023 through 2029.
The global market for Tumor Cell Isolation Kits in Diagnostic Laboratories is estimated to increase from $ million in 2023 to $ million by 2029, at a CAGR of % during the forecast period of 2023 through 2029.
The key global companies of Tumor Cell Isolation Kits include Thermo Fisher Scientific, Miltenyi Biotec, Cell Biolabs, Inc., STEMCELL Technologies Inc., QIAGEN, Genekam and Menarini Silicon Biosystems, Inc., etc. In 2022, the world’s top three vendors accounted for approximately % of the revenue.
Report Scope
This report aims to provide a comprehensive presentation of the global market for Tumor Cell Isolation Kits, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Tumor Cell Isolation Kits.
The Tumor Cell Isolation Kits market size, estimations, and forecasts are provided in terms of and revenue ($ millions), considering 2022 as the base year, with history and forecast data for the period from 2018 to 2029. This report segments the global Tumor Cell Isolation Kits market comprehensively. Regional market sizes, concerning products by type, by application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Tumor Cell Isolation Kits companies, new entrants, and industry chain related companies in this market with information on the revenues for the overall market and the sub-segments across the different segments, by company, by type, by application, and by regions.
By Company
Thermo Fisher Scientific
Miltenyi Biotec
Cell Biolabs, Inc.
STEMCELL Technologies Inc.
QIAGEN
Genekam
Menarini Silicon Biosystems, Inc.
Segment by Type
Breast Cancer Tumor Cell Isolation
Melanoma Tumor Cell Isolation
Ovarian Cancer Tumor Cell Isolation
Others
Segment by Application
Diagnostic Laboratories
Hospitals
Specialty Clinics
Research Laboratories
Others
By Region
North America
United States
Canada
Europe
Germany
France
UK
Italy
Russia
Nordic Countries
Rest of Europe
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia
Rest of Asia
Latin America
Mexico
Brazil
Rest of Latin America
Middle East & Africa
Turkey
Saudi Arabia
UAE
Rest of MEA
Core Chapters
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by type, application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Introduces executive summary of global market size, regional market size, this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter 3: Detailed analysis of Tumor Cell Isolation Kits companies’ competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6, 7, 8, 9, 10: North America, Europe, Asia Pacific, Latin America, Middle East and Africa segment by country. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 11: Provides profiles of key players, introducing the basic situation of the key companies in the market in detail, including product revenue, gross margin, product introduction, recent development, etc.
Chapter 12: The main points and conclusions of the report.
1 Report Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Tumor Cell Isolation Kits Market Size Growth Rate by Type: 2018 VS 2022 VS 2029
1.2.2 Breast Cancer Tumor Cell Isolation
1.2.3 Melanoma Tumor Cell Isolation
1.2.4 Ovarian Cancer Tumor Cell Isolation
1.2.5 Others
1.3 Market by Application
1.3.1 Global Tumor Cell Isolation Kits Market Growth by Application: 2018 VS 2022 VS 2029
1.3.2 Diagnostic Laboratories
1.3.3 Hospitals
1.3.4 Specialty Clinics
1.3.5 Research Laboratories
1.3.6 Others
1.4 Study Objectives
1.5 Years Considered
1.6 Years Considered
2 Global Growth Trends
2.1 Global Tumor Cell Isolation Kits Market Perspective (2018-2029)
2.2 Tumor Cell Isolation Kits Growth Trends by Region
2.2.1 Global Tumor Cell Isolation Kits Market Size by Region: 2018 VS 2022 VS 2029
2.2.2 Tumor Cell Isolation Kits Historic Market Size by Region (2018-2023)
2.2.3 Tumor Cell Isolation Kits Forecasted Market Size by Region (2024-2029)
2.3 Tumor Cell Isolation Kits Market Dynamics
2.3.1 Tumor Cell Isolation Kits Industry Trends
2.3.2 Tumor Cell Isolation Kits Market Drivers
2.3.3 Tumor Cell Isolation Kits Market Challenges
2.3.4 Tumor Cell Isolation Kits Market Restraints
3 Competition Landscape by Key Players
3.1 Global Top Tumor Cell Isolation Kits Players by Revenue
3.1.1 Global Top Tumor Cell Isolation Kits Players by Revenue (2018-2023)
3.1.2 Global Tumor Cell Isolation Kits Revenue Market Share by Players (2018-2023)
3.2 Global Tumor Cell Isolation Kits Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.3 Players Covered: Ranking by Tumor Cell Isolation Kits Revenue
3.4 Global Tumor Cell Isolation Kits Market Concentration Ratio
3.4.1 Global Tumor Cell Isolation Kits Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Tumor Cell Isolation Kits Revenue in 2022
3.5 Tumor Cell Isolation Kits Key Players Head office and Area Served
3.6 Key Players Tumor Cell Isolation Kits Product Solution and Service
3.7 Date of Enter into Tumor Cell Isolation Kits Market
3.8 Mergers & Acquisitions, Expansion Plans
4 Tumor Cell Isolation Kits Breakdown Data by Type
4.1 Global Tumor Cell Isolation Kits Historic Market Size by Type (2018-2023)
4.2 Global Tumor Cell Isolation Kits Forecasted Market Size by Type (2024-2029)
5 Tumor Cell Isolation Kits Breakdown Data by Application
5.1 Global Tumor Cell Isolation Kits Historic Market Size by Application (2018-2023)
5.2 Global Tumor Cell Isolation Kits Forecasted Market Size by Application (2024-2029)
6 North America
6.1 North America Tumor Cell Isolation Kits Market Size (2018-2029)
6.2 North America Tumor Cell Isolation Kits Market Growth Rate by Country: 2018 VS 2022 VS 2029
6.3 North America Tumor Cell Isolation Kits Market Size by Country (2018-2023)
6.4 North America Tumor Cell Isolation Kits Market Size by Country (2024-2029)
6.5 United States
6.6 Canada
7 Europe
7.1 Europe Tumor Cell Isolation Kits Market Size (2018-2029)
7.2 Europe Tumor Cell Isolation Kits Market Growth Rate by Country: 2018 VS 2022 VS 2029
7.3 Europe Tumor Cell Isolation Kits Market Size by Country (2018-2023)
7.4 Europe Tumor Cell Isolation Kits Market Size by Country (2024-2029)
7.5 Germany
7.6 France
7.7 U.K.
7.8 Italy
7.9 Russia
7.10 Nordic Countries
8 Asia-Pacific
8.1 Asia-Pacific Tumor Cell Isolation Kits Market Size (2018-2029)
8.2 Asia-Pacific Tumor Cell Isolation Kits Market Growth Rate by Region: 2018 VS 2022 VS 2029
8.3 Asia-Pacific Tumor Cell Isolation Kits Market Size by Region (2018-2023)
8.4 Asia-Pacific Tumor Cell Isolation Kits Market Size by Region (2024-2029)
8.5 China
8.6 Japan
8.7 South Korea
8.8 Southeast Asia
8.9 India
8.10 Australia
9 Latin America
9.1 Latin America Tumor Cell Isolation Kits Market Size (2018-2029)
9.2 Latin America Tumor Cell Isolation Kits Market Growth Rate by Country: 2018 VS 2022 VS 2029
9.3 Latin America Tumor Cell Isolation Kits Market Size by Country (2018-2023)
9.4 Latin America Tumor Cell Isolation Kits Market Size by Country (2024-2029)
9.5 Mexico
9.6 Brazil
10 Middle East & Africa
10.1 Middle East & Africa Tumor Cell Isolation Kits Market Size (2018-2029)
10.2 Middle East & Africa Tumor Cell Isolation Kits Market Growth Rate by Country: 2018 VS 2022 VS 2029
10.3 Middle East & Africa Tumor Cell Isolation Kits Market Size by Country (2018-2023)
10.4 Middle East & Africa Tumor Cell Isolation Kits Market Size by Country (2024-2029)
10.5 Turkey
10.6 Saudi Arabia
10.7 UAE
11 Key Players Profiles
11.1 Thermo Fisher Scientific
11.1.1 Thermo Fisher Scientific Company Detail
11.1.2 Thermo Fisher Scientific Business Overview
11.1.3 Thermo Fisher Scientific Tumor Cell Isolation Kits Introduction
11.1.4 Thermo Fisher Scientific Revenue in Tumor Cell Isolation Kits Business (2018-2023)
11.1.5 Thermo Fisher Scientific Recent Development
11.2 Miltenyi Biotec
11.2.1 Miltenyi Biotec Company Detail
11.2.2 Miltenyi Biotec Business Overview
11.2.3 Miltenyi Biotec Tumor Cell Isolation Kits Introduction
11.2.4 Miltenyi Biotec Revenue in Tumor Cell Isolation Kits Business (2018-2023)
11.2.5 Miltenyi Biotec Recent Development
11.3 Cell Biolabs, Inc.
11.3.1 Cell Biolabs, Inc. Company Detail
11.3.2 Cell Biolabs, Inc. Business Overview
11.3.3 Cell Biolabs, Inc. Tumor Cell Isolation Kits Introduction
11.3.4 Cell Biolabs, Inc. Revenue in Tumor Cell Isolation Kits Business (2018-2023)
11.3.5 Cell Biolabs, Inc. Recent Development
11.4 STEMCELL Technologies Inc.
11.4.1 STEMCELL Technologies Inc. Company Detail
11.4.2 STEMCELL Technologies Inc. Business Overview
11.4.3 STEMCELL Technologies Inc. Tumor Cell Isolation Kits Introduction
11.4.4 STEMCELL Technologies Inc. Revenue in Tumor Cell Isolation Kits Business (2018-2023)
11.4.5 STEMCELL Technologies Inc. Recent Development
11.5 QIAGEN
11.5.1 QIAGEN Company Detail
11.5.2 QIAGEN Business Overview
11.5.3 QIAGEN Tumor Cell Isolation Kits Introduction
11.5.4 QIAGEN Revenue in Tumor Cell Isolation Kits Business (2018-2023)
11.5.5 QIAGEN Recent Development
11.6 Genekam
11.6.1 Genekam Company Detail
11.6.2 Genekam Business Overview
11.6.3 Genekam Tumor Cell Isolation Kits Introduction
11.6.4 Genekam Revenue in Tumor Cell Isolation Kits Business (2018-2023)
11.6.5 Genekam Recent Development
11.7 Menarini Silicon Biosystems, Inc.
11.7.1 Menarini Silicon Biosystems, Inc. Company Detail
11.7.2 Menarini Silicon Biosystems, Inc. Business Overview
11.7.3 Menarini Silicon Biosystems, Inc. Tumor Cell Isolation Kits Introduction
11.7.4 Menarini Silicon Biosystems, Inc. Revenue in Tumor Cell Isolation Kits Business (2018-2023)
11.7.5 Menarini Silicon Biosystems, Inc. Recent Development
12 Analyst’s Viewpoints/Conclusions
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.2 Data Source
13.2 Disclaimer
13.3 Author Details